Raphael Ye, DO
Interventional Pain Medicine · Irving, TXNPI 1326314584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 869 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 80.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $4,105 and has fallen 98.7% since, to $53 in 2025.
Across 869 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Collegium Pharmaceutical, Inc.$313
- AbbVie$306
- Biohaven Pharmaceuticals, Inc.$261
- Zyla Life Sciences, Inc.$246
- Medtronic$159
- plus $1K from 21 others
What the payments were for
- Travel & lodging$2672%
- Food & beverage$13,12498%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 707 | $10,759 |
| Collegium Pharmaceutical, Inc. | 19 | $313 |
| AbbVie(2 entities) | 19 | $306 |
| Biohaven Pharmaceuticals, Inc. | 17 | $261 |
| Zyla Life Sciences, Inc. | 28 | $246 |
| Medtronic(2 entities) | 4 | $159 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $157 |
| Biodelivery Sciences International, Inc. | 18 | $143 |
| Boston Scientific | 1 | $139 |
| Saluda Medical Americas, Inc. | 2 | $118 |
| Pfizer | 6 | $111 |
| Amgen(2 entities) | 5 | $94 |
| Novartis | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Lilly USA, LLC | 4 | $61 |
| Forte Bio-pharma LLC | 2 | $60 |
| GRT US Holding, Inc. | 3 | $54 |
| IBSA Pharma Inc. | 4 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Foundation Fusion Solutions, LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Spinal Simplicity, LLC | 1 | $19 |
| MDD US Operations, LLC | 1 | $14 |
| Pernix Therapeutics Holdings, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$1,275
- Proclaim Family of SCS IPGs$1,151
- PROCLAIM$823
- GENERAL PAIN MANAGEMENT$139
- OCTRODE$136
- ADAPTIVESTIM$120
- ETERNA$101
How this compares
$13,391 in reported general payments places this provider in the 65th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $3,308 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $1,160 |
| Buprenorphine Hcl | 43 | $1,015 |
| Gabapentin | 56 | $668 |
| Oxycodone Hcl | 20 | $469 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $362 |
| Tramadol Hcl | 24 | $258 |
| Pregabalin | 12 | $191 |
| Tizanidine Hcl | 12 | $169 |
| Amitriptyline Hcl | 12 | $156 |
| Methylprednisolone | 16 | $122 |
| Cyclobenzaprine Hcl | 12 | $81 |
| Meloxicam | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Irving
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
- Thomas WhiteShenandoah$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.